Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Mohamed, W.W.; | Niazy, W.H.;
Affiliations: Division of Neonatology, Department of Pediatrics, Faculty of Medicine, Minia University, Minia, Egypt | Department of Pediatrics, College of Medicine, King Khalid University, Abha, Saudi Arabia | Department of Biochemistry, Faculty of Medicine, El-Minofya University, El-Minofya, Egypt | Department of Biochemistry, College of Medicine, King Khalid University, Abha, Saudi Arabia
Note: [] Corresponding author: Dr. Walid Abdel Wahab Eid Mohamed, Department of Pediatrics, College of Medicine, King Khalid University, P.O. Box 941, Abha, Saudi Arabia. Tel: +966 502507894; Fax: +966 72418194; E-mail: walidabdo2020@gmail.com
Abstract: Objective: To determine the possible genotoxic effect of phototherapy in term infants with hyperbilirubinemia. Patients and methods: A total of 172 term infants aged 3–10 days after birth were enrolled in the study. Newborns were divided into intensive phototherapy (n = 41), conventional phototherapy (n = 46), jaundiced control (n = 43), and non-jaundiced control (n = 42) groups. DNA damage, sister chromatid exchange (SCE) frequency, plasma total antioxidant capacity (TAC) and total oxidant status (TOS) levels were measured. Results: Before phototherapy, there were no significant differences between the four groups in terms of DNA damage, SCE frequency, TAC, or TOS (p > 0.05). After phototherapy, DNA damage, SCE frequency, and TOS were significantly higher in the intensive than in the conventional group (p < 0.05). In the phototherapy-treated groups, DNA damage and SCE frequency correlated positively with TOS (p < 0.05). Conclusion: Phototherapy may induce genotoxic effect in peripheral blood lymphocytes of term infants with hyperbilirubinemia.
Keywords: Phototherapy, DNA damage, term infants, hyperbilirubinemia
DOI: 10.3233/NPM-1261912
Journal: Journal of Neonatal-Perinatal Medicine, vol. 5, no. 4, pp. 381-387, 2012
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl